Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medical Genetics
Published in: BMC Medical Genetics 1/2010

Open Access 01-12-2010 | Research article

Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects

Authors: Tongfeng Zhao, Jiangpei Zhao

Published in: BMC Medical Genetics | Issue 1/2010

Login to get access

Abstract

Background

Studies examining the association of apolipoprotein A5 (APOA5) gene -1131 T>C polymorphism with blood lipids produced inconsistent results. In this meta-analysis encompassing all the relevant studies, we aimed to investigate the association of the -1131 T>C polymorphism with fasting blood lipids.

Methods

We limited our analysis to the following four blood lipid variables: total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Subjects were confined to adults who were at least 18 years old. A dominant model was used for this meta-analysis. 37 studies with 37859 subjects were included in this meta-analysis.

Results

The results showed that the carriers of -1131C allele have higher blood TC and TG than the non-carriers: standardized mean difference (SMD) = 0.08, 95% confidence interval (CI, 0.05, 0.11), P < 0.00001, P heterogeneity = 0.42, and SMD = 0.31, 95% CI (0.27, 0.34), P < 0.00001, P heterogeneity = 0.0003, respectively. Significant association between the -1131 T>C polymorphism and lower blood HDL-C was also detected under the dominant model: SMD = -0.17, 95% CI (-0.21, -0.14), P < 0.00001, P heterogeneity = 0.003.

Conclusions

Our meta-analysis supports the strong association of the APOA5 -1131 T>C polymorphism with higher levels of TC and TG, and lower levels of HDL-C.
Appendix
Available only for authorised users
Literature
1.
Menown IB, Murtagh G, Maher V, Cooney MT, Graham IM, Tomkin G: Dyslipidemia therapy update: the importance of full lipid profile assessment. Adv Ther. 2009, 7: 711-718. 10.1007/s12325-009-0052-3.CrossRef
2.
Garg A, Simha V: Update on dyslipidemia. J Clin Endocrinol Metab. 2007, 5: 581-589.
3.
Bosse Y, Chagnon YC, Despres JP, Rice T, Rao DC, Bouchard C, Pérusse L, Vohl MC: Genome-wide linkage scan reveals multiple susceptibility loci influencing lipid and lipoprotein levels in the Quebec Family Study. J Lipid Res. 2004, 3: 419-426.
4.
Tai ES, Ordovas JM: Clinical significance of apolipoprotein A5. Curr Opin Lipidol. 2008, 4: 349-354. 10.1097/MOL.0b013e328304b681.CrossRef
5.
Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001, 294: 169-173. 10.1126/science.1064852.CrossRefPubMed
6.
Elosua R, Ordovas JM, Cupples LA, Lai CQ, Demissie S, Fox CS, Polak JF, Wolf PA, D'Agostino RB Sr, O'Donnell CJ: Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study. J Lipid Res. 2006, 5: 990-996. 10.1194/jlr.M500446-JLR200.CrossRef
7.
Liu H, Zhang S, Lin J, Li H, Huang A, Xiao C, Li X, Su Z, Wang C, Nebert DW, Zhou B, Zheng K, Shi J, Li G, Huang D: Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism. 2005, 5: 568-572. 10.1016/j.metabol.2004.11.009.CrossRef
8.
Komurcu-Bayrak E, Onat A, Poda M, Humphries SE, Palmen J, Guclu F, Can G, Erginel-Unaltuna N: Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Clin Chem Lab Med. 2008, 6: 778-784. 10.1515/CCLM.2008.161.
9.
Hahne P, Krempler F, Schaap FG, Soyal SM, Höffinger H, Miller K, Oberkofler H, Strobl W, Patsch W: Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans. J Intern Med. 2008, 5: 452-462.CrossRef
10.
Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas JM, Lee JH: The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta. 2009, 1-2: 83-87. 10.1016/j.cca.2008.12.024.CrossRef
11.
Járomi L, Csöngei V, Polgár N, Szolnoki Z, Maász A, Horvatovich K, Faragó B, Sipeky C, Sáfrány E, Magyari L, Kisfali P, Mohás M, Janicsek I, Lakner L, Melegh B: Functional Variants of Glucokinase Regulatory Protein and Apolipoprotein A5 Genes in Ischemic Stroke. J Mol Neurosci.
12.
Sundl I, Guardiola M, Khoschsorur G, Solà R, Vallvé JC, Godàs G, Masana L, Maritschnegg M, Meinitzer A, Cardinault N, Roob JM, Rock E, Winklhofer-Roob BM, Ribalta J: Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation. J Lipid Res. 2007, 11: 2506-2513. 10.1194/jlr.M700285-JLR200.CrossRef
13.
Maasz A, Kisfali P, Jaromi L, Horvatovich K, Szolnoki Z, Csongei V, Safrany E, Sipeky C, Hadarits F, Melegh B: Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke. Circ J. 2008, 7: 1065-1070. 10.1253/circj.72.1065.CrossRef
14.
Kisfali P, Mohás M, Maász A, Polgár N, Hadarits F, Markó L, Brasnyó P, Horvatovich K, Oroszlán T, Bagosi Z, Bujtor Z, Gasztonyi B, Rinfel J, Wittmann I, Melegh B: Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis.
15.
Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, Perrot L, Le Coquil E, Sassolas A, Moulin P, Marcais C: Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin Chim Acta. 2008, 1-2: 99-103. 10.1016/j.cca.2008.04.013.CrossRef
16.
Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, Joglekar CV, Fall CH, Mohankrishna P, Wilkin TJ, Metcalf BS, Weedon MN, Frayling TM, Hattersley AT: Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. BMC Med Genet. 2006, 7: 76-10.1186/1471-2350-7-76.CrossRefPubMedPubMedCentral
17.
Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, Corrocher R, Olivieri O: The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study. Atherosclerosis. 2007, 2: 409-417. 10.1016/j.atherosclerosis.2006.04.009.CrossRef
18.
Hodoglugil U, Tanyolaç S, Williamson DW, Huang Y, Mahley RW: Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. J Lipid Res. 2006, 1: 144-153.
19.
Szalai C, Keszei M, Duba J, Prohászka Z, Kozma GT, Császár A, Balogh S, Almássy Z, Fust G, Czinner A: Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis. 2004, 1: 109-114. 10.1016/j.atherosclerosis.2003.12.003.CrossRef
20.
Talmud PJ, Martin S, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Humphries SE, Syvänne M: APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res. 2004, 4: 750-756. 10.1194/jlr.M300458-JLR200.CrossRef
21.
Girona J, Guardiola M, Cabré A, Manzanares JM, Heras M, Ribalta J, Masana L: The apolipoprotein A5 gene -1131T-->C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients. Clin Chem Lab Med. 2008, 4: 453-457. 10.1515/CCLM.2008.110.
22.
Huang MC, Wang TN, Wang HS, Sung YC, Ko YC, Chiang HC: The -1131T>C polymorphism in the apolipoprotein A5 gene is related to hypertriglyceridemia in Taiwanese aborigines. Kaohsiung J Med Sci. 2008, 4: 171-179. 10.1016/S1607-551X(08)70114-1.CrossRef
23.
Chien KL, Fang WH, Wen HC, Lin HP, Lin YL, Lin SW, Wu JH, Kao JT: APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta. 2008, 1-2: 56-62. 10.1016/j.cca.2007.12.014.CrossRef
24.
Yamada Y, Matsuo H, Warita S, Watanabe S, Kato K, Oguri M, Yokoi K, Metoki N, Yoshida H, Satoh K, Ichihara S, Aoyagi Y, Yasunaga A, Park H, Tanaka M, Nozawa Y: Prediction of genetic risk for dyslipidemia. Genomics. 2007, 5: 551-558. 10.1016/j.ygeno.2007.08.001.CrossRef
25.
Yamada Y, Kato K, Hibino T, Yokoi K, Matsuo H, Segawa T, Watanabe S, Ichihara S, Yoshida H, Satoh K, Nozawa Y: Prediction of genetic risk for metabolic syndrome. Atherosclerosis. 2007, 2: 298-304. 10.1016/j.atherosclerosis.2006.05.035.CrossRef
26.
Hsu LA, Ko YL, Chang CJ, Hu CF, Wu S, Teng MS, Wang CL, Ho WJ, Ko YS, Hsu TS, Lee YS: Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis. 2006, 1: 143-149. 10.1016/j.atherosclerosis.2005.05.031.CrossRef
27.
Bi N, Yan SK, Li GP, Yin ZN, Chen BS: A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab. 2004, 3: 280-286. 10.1016/j.ymgme.2004.06.017.CrossRef
28.
Jang Y, Kim JY, Kim OY, Lee JE, Cho H, Ordovas JM, Lee JH: The -1131T-->C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr. 2004, 4: 832-840.
29.
Li GP, Wang JY, Yan SK, Chen BS, Xue H, Wu G: Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population. Clin Genet. 2004, 6: 470-476. 10.1111/j.1399-0004.2004.00251.x.CrossRef
30.
Li X, Xu Y, Ding Y, Qin C, Dai Z, Niu L: Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes. J Huazhong Univ Sci Technolog Med Sci. 2008, 6: 653-656.CrossRef
31.
Hsu LA, Ko YL, Chang CJ, Teng MS, Wu S, Hu CF: Apolipoprotein A5 gene -1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan. Clin Chem Lab Med. 2008, 12: 1714-1719. 10.1515/CCLM.2008.352.
32.
Yan SK, Cheng XQ, Song YH, Xiao XH, Bi N, Chen BS: Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese. Clin Chem Lab Med. 2005, 6: 607-612. 10.1515/CCLM.2005.105.
33.
Lai CQ, Tai ES, Tan CE, Cutter J, Chew SK, Zhu YP, Adiconis X, Ordovas JM: The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res. 2003, 12: 2365-273. 10.1194/jlr.M300251-JLR200.CrossRef
34.
Aouizerat BE, Kulkarni M, Heilbron D, Drown D, Raskin S, Pullinger CR, Malloy MJ, Kane JP: Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res. 2003, 6: 1167-1173. 10.1194/jlr.M200480-JLR200.CrossRef
35.
Aberle J, Evans D, Beil FU, Seedorf U: A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet. 2005, 2: 152-154. 10.1111/j.1399-0004.2005.00463.x.CrossRef
36.
Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC: Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2002, 24: 3031-3038. 10.1093/hmg/11.24.3031.CrossRef
37.
Olano-Martin E, Abraham EC, Gill-Garrison R, Valdes AM, Grimaldi K, Tang F, Jackson KG, Williams CM, Minihane AM: Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender. J Lipid Res. 2008, 5: 945-953. 10.1194/jlr.M700112-JLR200.CrossRef
38.
Chaaba R, Attia N, Hammami S, Smaoui M, Mahjoub S, Hammami M, Masmoudi AS: Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Dis. 2005, 4: 1-10.1186/1476-511X-4-1.CrossRefPubMedPubMedCentral
39.
Mattei J, Demissie S, Tucker KL, Ordovas JM: Apolipoprotein A5 polymorphisms interact with total dietary fat intake in association with markers of metabolic syndrome in Puerto Rican older adults. J Nutr. 2009, 12: 2301-2308.CrossRef
40.
Hubacek JA, Skodová Z, Lánská V, Adámková V: Apolipoprotein A-V variant (T-1131>C) affects plasma levels of non-high-density lipoprotein cholesterol in Caucasians. Exp Clin Cardiol. 2008, 3: 129-132.
41.
Baum L, Tomlinson B, Thomas GN: APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet. 2003, 5: 377-379. 10.1034/j.1399-0004.2003.00063.x.CrossRef
42.
Baum L, Ng MC, So WY, Poon E, Wang Y, Lam VK, Tomlinson B, Chan JC: A case-control study of apoA5 -1131T-->C polymorphism that examines the role of triglyceride levels in diabetic nephropathy. J Diabetes Complications. 2007, 3: 158-163. 10.1016/j.jdiacomp.2006.02.003.CrossRef
43.
Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K: Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol. 2009, 9: 1158-1165. 10.1093/aje/kwp014.CrossRef
44.
Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res. 1993, 2: 121-145. 10.1177/096228029300200202.CrossRefPubMed
45.
Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM: Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006, 6: 50-10.1186/1471-2288-6-50.CrossRefPubMedPubMedCentral
46.
47.
Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simples, graphical test. BMJ. 1997, 315: 629-634-PubMedPubMedCentral
48.
Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR: Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 2008, 2: 161-169. 10.1038/ng.76.CrossRef
49.
Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008, 2: 189-197. 10.1038/ng.75.CrossRef
50.
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J: Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010, 9726: 1634-1639.
51.
Ioannidis JP, Trikalinos TA, Ntzani EN, Contopoulos-Ioannidis DG: Genetic associations in large versus small studies: an empirical assessment. Lancet. 2003, 361: 567-571-10.1016/S0140-6736(03)12516-0.CrossRefPubMed
52.
Priore Oliva C, Carubbi F, Schaap FG, Bertolini S, Calandra S: Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene. J Intern Med. 2008, 4: 450-458. 10.1111/j.1365-2796.2007.01912.x.CrossRef
Metadata
Title
Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects
Authors
Tongfeng Zhao
Jiangpei Zhao
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2010
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-11-120

Other articles of this Issue 1/2010

BMC Medical Genetics 1/2010 Go to the issue

Research article

Genetic testing of newborns for type 1 diabetes susceptibility: a prospective cohort study on effects on maternal mental health

Research article

Evaluation of 6 candidate genes on chromosome 11q23 for coeliac disease susceptibility: a case control study

Research article

Genes encoding critical transcriptional activators for murine neural tube development and human spina bifida: a case-control study

Research article

Prevalence of 22q11.2 microdeletion in 146 patients with cardiac malformation in a referral hospital of North India

Research article

Important role of indels in somatic mutations of human cancer genes

Research article

The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study